Skip to content
Screener

Disc Medicine IRON Other income, net (Note 6)

Other income, net (Note 6) at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$24.3M+84.1%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$81K-325%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$119K-77.2%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$1.61M+126%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
-$91K-117%
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.97B+45.5%
Enterprise value$2.92B+49.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Disc Medicine’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 8:33 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-205192
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Other income (expense), net:
Interest income6,8936,880
Interest expense(844)(897)
Other income (expense)22(3)
Total other income (expense), net6,0715,980
Loss before income taxes(63,453)(33,966)
Income tax expense(51)(119)
Net loss$(63,504)$(34,085)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Disc Medicine's other income, net (note 6)?
Disc Medicine (IRON) reported other income, net (note 6) of $22K in Q1 2026.
How has Disc Medicine's other income, net (note 6) changed year-over-year?
Disc Medicine's other income, net (note 6) increased by 833.3% year-over-year, from -$3K to $22K.
What is the long-term trend for Disc Medicine's other income, net (note 6)?
Over 3 years (2021 to 2025), Disc Medicine's other income, net (note 6) has grown at a 53.5% compound annual growth rate (CAGR), from -$13K to $47K.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about Disc Medicine's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude